Expression and significance of MiR-126 and VEGF in proliferative diabetic retinopathy

被引:16
|
作者
Liu, R. [1 ]
Liu, C-M [2 ]
Cui, L-L [1 ]
Zhou, L. [3 ]
Li, N. [1 ]
Wei, X-D [1 ]
机构
[1] Tangshan Worker Hosp, Dept Ophthalmol, Tangshan, Peoples R China
[2] Tangshan Worker Hosp, Dept Emergency Med, Tangshan, Peoples R China
[3] Tangshan Worker Hosp Grp Rehabil Hosp, Dept Ophthalmol, Tangshan, Peoples R China
关键词
MiR-126; VEGF; Proliferative diabetic retinopathy; GROWTH; NEOVASCULARIZATION; MICRORNA-126;
D O I
10.26355/eurrev_201908_18518
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To study the expression and significance of micro ribonucleic acid (miR)-126 and vascular endothelial growth factor (VEGF) in the vitreous body and proliferative membrane tissues of affected eyes and plasma in proliferative diabetic retinopathy (PDR). PATIENTS AND METHODS: A total of 50 PDR patients admitted to our hospital from January 2017 to January 2018 were collected, including 17 cases in stage IV, 20 cases in stage V, and 13 cases in stage VI according to the DR staging criteria. Another 30 patients with an idiopathic macular hole were selected as control group. After admission, the examinations were performed, venous blood was drawn, and vitrectomy was performed, during which the vitreous body and proliferative membrane tissues were taken. The plasma VEGF content was detected via enzyme-linked immunosorbent assay (ELISA). The VEGF protein expression level was detected via Western blotting in vitreous body and proliferative membrane tissues. Moreover, the miR-126 expression was detected via quantitative polymerase chain reaction (qPCR). RESULTS: In the vitreous body tissues, proliferative membrane tissues and plasma, the expression level of miR-126 was significantly lower in control group than that in stage IV, V, and VI groups (p<0.05). The miR-126 expression was significantly lower in stage IV group than that in stage V and VI groups (p<0.05), meanwhile, miR-126 expression was significantly lower in stage V group than that in stage VI group (p<0.05). In the vitreous body tissues, proliferative membrane tissues and plasma, the VEGF mRNA and protein expression levels were significantly higher in control group than those in stage IV, V, and VI groups (p<0.05). The VEGF expressions were significantly higher in stage IV group than those in stage V and VI groups (p<0.05). In addition, VEGF expressions were significantly higher in stage V group than those in stage VI group (p<0.05). Furthermore, the VEGF expression level was negatively correlated with the miR-126 expression level. CONCLUSIONS: We found that the abnormally high expression of miR-126 negatively regulates VEGF, which may be one of the important mechanisms of occurrence of PDR. The miR-126 and VEGF content can serve as important predictors for the condition of PDR.
引用
收藏
页码:6387 / 6393
页数:7
相关论文
共 50 条
  • [21] MiR-126 in Hepatocellular Carcinoma and Cholangiocellular Carcinoma: A Reappraisal with an in situ Detection of miR-126
    Zailaie, Samar A.
    Sergi, Consolato M.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2022, 52 (01): : 73 - 85
  • [22] THE SIGNIFICANCE OF VITRONECTIN IN PROLIFERATIVE DIABETIC-RETINOPATHY
    ESSER, P
    BRESGEN, M
    WELLER, M
    HEIMANN, K
    WIEDEMANN, P
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1994, 232 (08) : 477 - 481
  • [23] Deregulation of mir-126 and mir-126*in primary lung tumors and lymph node metastasis
    Carvalho, L.
    Silva, M. R.
    Romano, S.
    Santos, P.
    Teixeira, L.
    D'Aguiar, M. J.
    VIRCHOWS ARCHIV, 2011, 459 : S321 - S321
  • [24] Laser or Anti-VEGF for proliferative diabetic retinopathy
    Parikakis, E.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 94 - 94
  • [25] Combination of serum HMGB-1 and serum miR-126 achieve high predictive power to detect proliferative diabetic retinopathy: a Chinese population-based study
    Hui, Ying
    Yin, Yan
    Tian, Dong Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 5909 - 5914
  • [26] Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients
    Tomasetti, Marco
    Staffolani, Sara
    Nocchi, Linda
    Neuzil, Jiri
    Strafella, Elisabetta
    Manzella, Nicola
    Mariotti, Laura
    Bracci, Massimo
    Matteo, Valentino A.
    Amati, Monica
    Santarelli, Lory
    CLINICAL BIOCHEMISTRY, 2012, 45 (7-8) : 575 - 581
  • [27] Prognostic significance of miR-126 in various cancers: a meta-analysis
    Dong, Yuanli
    Fu, Chengrui
    Guan, Hui
    Zhang, Zicheng
    Zhou, Tao
    Li, Baosheng
    ONCOTARGETS AND THERAPY, 2016, 9 : 2547 - 2555
  • [28] The renoprotective role of miR-126
    David Holmes
    Nature Reviews Nephrology, 2014, 10 (5) : 242 - 242
  • [29] Expression, regulation and function of miR-126 in the mouse choroid vasculature
    Zhao, Fangkun
    Anderson, Chastain
    Karnes, Sara
    Zhou, Qinbo
    Ma, Jing
    Jin, Zheng-Gen
    Bhattacharjee, Partha S.
    Wang, Shusheng
    EXPERIMENTAL EYE RESEARCH, 2018, 170 : 169 - 176
  • [30] Hypoxia-Induced Deregulation of miR-126 and Its Regulative Effect on VEGF and MMP-9 Expression
    Ye, Panpan
    Liu, Jian
    He, Fengying
    Xu, Wen
    Yao, Ke
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (01): : 17 - 23